Effect of felodipine on renal haemodynamics and tubular sodium handling after single-dose cyclosporin infusion in renal transplant recipients treated with azathioprine and prednisolone

References

• Thompson M E., Shapiro A P., Johnsen A M., Itzkoff J M., Hardesty R L., Griffith B P., et al. The contrasting effects of cyclosporin-A and azathioprine on arterial blood pressure and renal function following cardiac transplantation. Int J Cardiol 1986; 11: 219–29
   PubMed Web of Science ®Google Scholar
• Iwatsuki S, Esquivel C O., Klintmalm G B., Gordon R D., Shaw B W., Jr., Starzl T E. Nephrotoxicity of cyclosporine in liver transplantation. Transplant Proc 1985; 17: 191–5
   PubMedGoogle Scholar
• Myers B D., Ross J, Newton L, Luetscher J, Perlroth M. Cyclosporine-associated chronic nephropathy. N Engl J Med 1984; 311: 699–705
   PubMed Web of Science ®Google Scholar
• Curtis J J., Luke R G., Dubovsky E, Diethelm A G., Whelchel J D., Jones P. Cyclosporin in therapeutic doses increases renal allograft vascular resistance. Lancet 1986; 2: 477–9
   PubMed Web of Science ®Google Scholar
• Leonetti G, Gradnik R, Terzoli L, Fruscio M, Rupoli L, Cuspidi C, et al. Effects of single and repeated doses of the calcium antagonist felodipine on blood pressure, renal function, electrolytes and water balance, and renin–angiotensin–aldosterone system in hypertensive patients. J Cardiovasc Pharmacol 1986; 8: 1243–18
   PubMed Web of Science ®Google Scholar
• Herlitz H, Aurell M, Bjorck S, Granerus G. Renal effects of felodipine in hypertensive patients with reduced renal function. Drugs 1985; 29: 192–7, Suppl 2
   PubMedGoogle Scholar
• Neumayer H H., Wagner K. Prevention of delayed graft function in cadaver kidney transplants by diltiazem: outcome of two prospective, randomized clinical trials. J Cardiovasc Pharmacol 1987; 10: S170–7, Suppl 10
   Google Scholar
• Morales J M., Andres A, Prieto C, Ortuno B, Estenoz J, Dorado C, et al. Calcium antagonist treatment of recipients minimizes early cyclosporine nephrotoxicity in renal transplantation: a prospective randomized trial. Transplant Proc 1989; 21: 1537–19
   PubMed Web of Science ®Google Scholar
• Ferguson C J., Williams J D., Hillis A N., Parry-Jones D, Salaman J R. Effects of the calcium channel blocker diltiazem on cyclosporin nephrotoxicity in renal transplant patients. Clin Transplantation 1992; 6: 391–8
   Google Scholar
• Pirsch J D., D'Alessandro A M., Roecker E B., Knechtle S J., Reed A, Sollinger H W., et al. A controlled, double-blind, randomized trial of verapamil and cyclosporine in cadaver renal transplant patients. Am J Kidney Dis 1993; 21: 189–95
   PubMedGoogle Scholar
• Sorensen S S., Skovbon H, Eiskjaer H, Thomsen K, Pedersen E B. Effect of felodipine on renal haemo-dynamics and tubular sodium handling in cyclosporin-treated renal transplant recipients. Nephrol Dial Transplant 1992; 7: 69–78
   PubMed Web of Science ®Google Scholar
• Berg K J., Holdaas H, Endresen L, Fauchald P, Hartmann A, Pran T, et al. Effects of isradipine on renal function in cyclosporin-treated renal transplanted patients. Nephrol Dial Transplant 1991; 6: 725–30
   PubMed Web of Science ®Google Scholar
• Ruggenenti P, Perico N, Mosconi L, Gaspari F, Benigni A, Amuchastegui C S., et al. Calcium channel blockers protect transplant patients from cyclosporine-induced daily renal hypoperfusion. Kidney Int 1993; 43: 706–11
   PubMed Web of Science ®Google Scholar
• Kappelgaard A M., Nielsen M D., Giese J. Measurement of angiotensin II in human plasma: technical modifications and practical experience. Clin Chim Acta 1976; 67: 299–306
   PubMed Web of Science ®Google Scholar
• Rask-Madsen J, Bruusgaard A, Munck O, Nielsen M D., Worming H. The significance of bile acids and aldosterone for the electrical hyperpolarization of human rectum in obese patients treated with intestinal by-pass operation. Scand J Gastroenterol 1975; 9: 217–46
   Web of Science ®Google Scholar
• Thomassen A R., Bagger J P., Nielsen T T., Pedersen E B. Atrial natriuretic peptide during pacing in controls and patients with coronary arterial disease. Int J Cardiol 1987; 17: 267–79
   PubMed Web of Science ®Google Scholar
• Pedersen E B., Danielsen H, Spencer E S. Effect of indapamide on renal plasma flow, glomerular filtration rate and arginine vasopressin in plasma in essential hypertension. Eur J Clin Pharmacol 1984; 26: 543–7
   PubMed Web of Science ®Google Scholar
• Sumpio B, Baue A E., Chaudry I H. Treatment with verapamil and adenosine triphosphate-MgCl2 reduces cyclosporine nephrotoxicity. Surgery 1987; 101: 315–22
   PubMed Web of Science ®Google Scholar
• McNally P G., Baker F, Mistry N, Walls J, Feehally J. Effect of nifedipine on renal haemo-dynamics in an animal model of cyclosporin A nephrotoxicity. Clin Sci 1990; 79: 259–66
   Google Scholar
• Morales J M., Andres A, Alvarez C, Prieto C, Ortuno B, Ortuno T, et al. Calcium channel blockers and early cyclosporine nephrotoxicity after renal transplantation: a prospective randomized study. Transplant Proc 1990; 22: 1733–15
   PubMed Web of Science ®Google Scholar
• Weir M R., Klassen D K., Shen S Y., Sullivan D, Buddemeyer E U., Handwerger B S. Acute effects of intravenous cyclosporine on renal function in healthy humans. Transplant Proc 1989; 21: 915–7
   PubMedGoogle Scholar
• Conte G, Dal-Canton A, Sabbatini M, Napodano P, De-Nicola L, Gigliotti G, et al. Acute cyclosporine renal dysfunction reversed by dopamine infusion in healthy subjects. Kidney Int 1989; 36: 1086–92
   PubMedGoogle Scholar
• Sorensen S S. Radio-immunoassay of endothelin in human plasma. Scand J Clin Lab Invest 1991; 51: 615–23
   PubMed Web of Science ®Google Scholar
• Koomans H A., Boer W H., Dorhout-Mees E J. Evaluation of lithium clearance as a marker of proximal tubule sodium handling. Kidney Int 1989; 36: 2–12
   PubMed Web of Science ®Google Scholar